A large number of mutations in JAK3 have been identified in immune cell cancers, the majority being within the pseudo-PTK and PTK domains, with the most common being M511I, A573V and R657A in the pseudo-PTK domain, although no clear correlation of specific mutations with cancer type has been identified [39] (Figure 3). Here, JAK3 is linked to cancer.